Gout is a form of inflammatory arthritis. It occurs when excess uric acid in the blood leads to deposits of uric acid crystals in one or more joints. These deposits cause inflammation in your joints. The underlying cause of gout is excess uric acid in the blood – a metabolic disorder called hyperuricemia.
The study will evaluate whether a 12-month course of an investigational drug, called tigulixostat, can reduce uric acid levels for people with gout and high uric acid levels.
Your participation will last between 12 – 14 months, and you will be required to come to our clinic between 14 and 17 times during that period. At each visit you will see the study doctor and then the research team for study assessments
There is no cost for the study medication or care, and you will be compensated for time and travel.
You may be eligible to participate if:
- You are aged 18- 85
- You have high uric acid levels
- You have gout or a history of gout
- You do NOT consume more than 14 beers or the equivalent per week
Further eligibility criteria apply.
Register your interest
Please contact Holdsworth House Research to register your interest, or, use the form to request more information.